SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Integrative Cancer Therapies
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Block, K. I.
Right arrow Articles by Gyllenhaal, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Block, K. I.
Right arrow Articles by Gyllenhaal, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Clinical Corner: Herb-Drug Interactions in Cancer Chemotherapy: Theoretical Concerns Regarding Drug Metabolizing Enzymes

Keith I. Block, MD

Charlotte Gyllenhaal, PhD

Interactions between herbal medicines and conventional drugs have recently been reported; the most significant herb with such drug interactions is Saint John's wort, an inducer of cytochrome P450 3A3/4, an enzyme responsible for clearance of many clinically important drugs from the body. Foods (especially grapefruit) and habits or lifestyle factors such as smoking or alcohol consumption may also alter the metabolism of drugs through effects on the cytochrome P450 system. The authors review here the functioning of the drug-metabolizing enzymes and discuss their particular sig nificance in cancer chemotherapy treatment. They then present the herbal medicines, foods, and lifestyle factors that induce or inhibit drug-metabolizing enzymes that are important for both cancer chemotherapy drugs and drugs used adjunctively in cancer treatment. It is notable that no actual herb-drug interactions have been reported clinically in cancer treatment, and their potential for interaction still must be regarded as theoretical. Although some chemotherapy patients may be interested in taking herbal medicines that could potentially interact with cancer chemotherapy agents, it may be wise to counsel them to use other means of addressing the problems for which they use specific herbs during the time they receive chemotherapy.

Integrative Cancer Therapies, Vol. 1, No. 1, 83-89 (2002)
DOI: 10.1177/153473540200100118


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Journal of Pediatric Oncology NursingHome page
J. Post-White
Complementary and Alternative Medicine in Pediatric Oncology
Journal of Pediatric Oncology Nursing, September 1, 2006; 23(5): 244 - 253.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
K N Woodward
The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products
Human and Experimental Toxicology, May 1, 2005; 24(5): 219 - 233.
[Abstract] [PDF]


Home page
Integr Cancer TherHome page
K. I. Block, C. Gyllenhaal, and M. N. Mead
Safety and Efficacy of Herbal Sedatives in Cancer Care
Integr Cancer Ther, June 1, 2004; 3(2): 128 - 148.
[Abstract] [PDF]


Home page
Integr Cancer TherHome page
K. I. Block, B. Burns, A. J. Cohen, A. S. Dobs, S. M. Hess, and A. Vickers
Point-Counterpoint: Using Clinical Trials for the Evaluation of Integrative Cancer Therapies
Integr Cancer Ther, March 1, 2004; 3(1): 66 - 81.
[PDF]